Literature DB >> 1859478

Treatment of collagen-induced arthritis in rats with a monoclonal antibody against the alpha/beta T cell antigen receptor.

S Yoshino1, L G Cleland, G Mayrhofer.   

Abstract

A monoclonal antibody (MAb) to the alpha/beta T cell receptor (TCR alpha/beta), R73 MAb, completely blocked the induction of collagen-induced arthritis (CIA) in rats when the MAb was administered at the time of immunization with type II collagen. When administered after CIA had begun, the progression of the arthritis was suppressed significantly by R73 MAb treatment. The preventive and suppressive effects of R73 MAb on CIA were associated with the depletion of peripheral blood alpha/beta-positive T cells. These results indicate that alpha/beta-positive T cells play a role in the progression of existing CIA as well as in its induction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1859478     DOI: 10.1002/art.1780340814

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

1.  Genetic regulation of T regulatory, CD4, and CD8 cell numbers by the arthritis severity loci Cia5a, Cia5d, and the MHC/Cia1 in the rat.

Authors:  Max Brenner; Teresina Laragione; Nuriza C Yarlett; Pércio S Gulko
Journal:  Mol Med       Date:  2007 May-Jun       Impact factor: 6.354

Review 2.  Combination therapy in mice: what can we learn that may be useful for understanding rheumatoid arthritis?

Authors:  R O Williams
Journal:  Springer Semin Immunopathol       Date:  1998

3.  The role of lipopolysaccharide injected systemically in the reactivation of collagen-induced arthritis in mice.

Authors:  S Yoshino; M Ohsawa
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 4.  The genetic and immunopathological processes underlying collagen-induced arthritis.

Authors:  J A Luross; N A Williams
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

5.  Resistance to development of collagen-induced arthritis in C57BL/6 mice is due to a defect in secondary, but not in primary, immune response.

Authors:  Meng Pan; Insoo Kang; Joe Craft; Zhinan Yin
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

6.  Increased activation-induced cell death in peripheral lymphocytes of rheumatoid arthritis patients: the mechanism of action.

Authors:  Xiaolei Tang; David E Yocum; David Dejonghe; Kathryn Nordensson; Douglas F Lake; John Richard
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

7.  Anti-CD5 therapy decreases severity of established disease in collagen type II-induced arthritis in DBA/1 mice.

Authors:  C Plater-Zyberk; P C Taylor; M G Blaylock; R N Maini
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.